Literature DB >> 4004524

Posttraumatic syringomyelia.

G E Dworkin, W E Staas.   

Abstract

Posttraumatic syringomyelia can be a subtle entity initially. Awareness of the early clinical manifestations is a necessary adjunct in preventing the disabling sequela. Four case reports are examined with emphasis on temporal progression of symptoms and the resultant functional loss. The salient clinical features and a description of their pathogenesis are summarized. The presenting symptoms and signs were upper extremity reflex loss, musculoskeletal-type pain, and arm numbness. The functional impairments which resulted included the following: increased assistance with wheelchair mobility, significantly reduced performance of ADL, and loss of walking skill in a previously independent ambulator. Each patient underwent myelography (insufficient alone) as well as contrast CT scanning. Each patient underwent shunting with only one patient benefiting significantly. Syrinx formation must be included in the differential diagnosis of neuromuscular complaints by the spinal cord injured (SCI) population and treated appropriately.

Entities:  

Mesh:

Year:  1985        PMID: 4004524

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  2 in total

Review 1.  Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury.

Authors:  B Schurch; W Wichmann; A B Rossier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

Review 2.  Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment).

Authors:  Alfredo Avellaneda Fernández; Alberto Isla Guerrero; Maravillas Izquierdo Martínez; María Eugenia Amado Vázquez; Javier Barrón Fernández; Ester Chesa i Octavio; Javier De la Cruz Labrado; Mercedes Escribano Silva; Marta Fernández de Gamboa Fernández de Araoz; Rocío García-Ramos; Miguel García Ribes; Carmen Gómez; Joaquín Insausti Valdivia; Ramón Navarro Valbuena; José R Ramón
Journal:  BMC Musculoskelet Disord       Date:  2009-12-17       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.